Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Q4 2023 Earnings Call Transcript
Operator: Welcome to the Calliditas Therapeutics Q4 2023 Report. For the first part of the conference call, the participants will be in listen-only mode.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 750,000 | $19,327,500 | 0.48% | |
2. | Ironwood Investment Management Warren Isabelle | 25,435 | $654,799 | -5% | 0.34% |
3. | 10,000 | $257,700 | +82% | 0% | |
4. | 9,100 | $234,507 | +238% | 0% | |
5. | Citadel Investment Group Ken Griffin | 827 | $21,312 | -84% | 0% |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 50,550 | $1,301,157 | 0% | |
2. | 31,600 | $814,332 | 0% | |
3. | 14,400 | $371,088 | 0% | |
4. | 9,412 | $242,547 | 0% | |
5. | 2,000 | $51,540 | 0% |